Results 151 to 160 of about 6,721,239 (285)

Stable Isotope Analysis (δ¹³C, δ¹⁵N and δ¹⁸O) of Killer Whale Dentine: Evaluating Treatment Methods and Establishing Best Practices. [PDF]

Rapid Commun Mass Spectrom
Terrapon M, Hammond PS, McGill RAR, Newton J, Dougans J, Matthews CJD, Hooker SK.   +6 more
europepmc   +1 more source

Inter‐ and intraspecific variation in theropod dinosaur dental microwear and its palaeoecological implications

The Anatomical Record, EarlyView.
Abstract Differences in skull and tooth morphology, stomach contents, and estimated bite force between medium‐to‐large sized (≥100 kg) predatory theropod dinosaurs have long been suspected to correlate with differences in their diets and dietary guilds (e.g., hypercarnivory, piscivory).
Cassius Morrison, James Gregory, Christopher Jackson, Jordan Bestwick, Katlin Schroeder, Samuel J.L. Gascoigne, Paul Bills, Laura B. Porro, Philip D. Mannion, Paul M. Barrett   +9 more
wiley   +1 more source

Osteohistological evidence for terrestrial adaptation and an extended growth period in mekosuchine crocodylians and its potential role in their extinction

The Anatomical Record, EarlyView.
Abstract The Australasian crocodylian fossil record is dominated by the extinct endemic clade Mekosuchinae, with known members spanning the Eocene‐to‐Holocene. This diverse clade exhibited high morphological disparity, from early members superficially similar to Crocodylus, to more terrestrial forms later in the clade's evolutionary history.
Devin K. Hoffman, Cecily S. C. Nicholl, Oliver Bradley, Sreya Magar, Marie Sofia Sebaratnam, Alexandra Houssaye, Ryan N. Felice, Adam M. Yates, Stephen F. Poropat, Philip D. Mannion   +9 more
wiley   +1 more source

Ranking targeted therapies in advanced pancreatic adenocarcinoma: insights from a network meta-analysis. [PDF]

J Gastrointest Oncol
Saif MW, Philip PA, Azmi AS.
europepmc   +1 more source

Byron II Presents Quail Ridge

, 1994
Wine "Ms.
Byron II
core  

High Rate of Return to Sport in Competitive Athletes Undergoing Periacetabular Osteotomy With Concomitant Hip Arthroscopy

Arthroscopy, EarlyView.
Purpose To report the return‐to‐sport rate of competitive athletes with hip dysplasia, in relation to their preoperative level of competition, who underwent hip arthroscopy with concomitant periacetabular osteotomy (HA + PAO). Methods Patients participating in competitive sports who underwent HA + PAO for the correction of hip dysplasia between January
Alfred Mansour, Nicole Lemaster, Jacob Jelmini, Philip Sheedy, Anota Adekunle, Alexis Aboulafia   +5 more
wiley   +1 more source

Validating KCCQ-12 Meaningful Change Thresholds in Real-World Ambulatory HFpEF Care. [PDF]

JACC Heart Fail
Russell D, Chau K, Berg KY, Zarzuela K, Reich A, Savaram S, Kang JA, Bang SH, Jones PG, Spertus JA, Turchioe MR, Goyal P, Masterson Creber RM.   +12 more
europepmc   +1 more source

Periportal Capsulotomy Shows Promising Short‐Term Outcomes Compared With an Interportal Capsulotomy for the Treatment of Femoroacetabular Impingement Syndrome in Borderline and Dysplastic Female Patients

Arthroscopy, EarlyView.
Purpose To compare patient‐reported outcomes (PROs) and revision rates between borderline and dysplastic women who underwent an interportal capsulotomy approach versus a capsular sparing periportal capsulotomy approach for the treatment of femoroacetabular impingement syndrome. Methods Female patients with a lateral center edge angle ≤25° who underwent
Benjamin T. Johnson, Allan K. Metz, Zoe D. Trutner, Charles L. Holliday, Keaton Andra, Collin D. R. Hunter, Stephen K. Aoki   +6 more
wiley   +1 more source

Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real-World Multisite Cohort Study. [PDF]

Acta Psychiatr Scand
Lyndon S, Gibbons JB, Straub L, Sung M, Jameson JC, Hathaway DB, Mulcahy DH, Elliott C, Wood R, Ruble M, Szmulewicz AG, Yang J, Aldis R, Wyss R, Wang PS, Siddiqi SH.   +15 more
europepmc   +1 more source

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

Arthritis &Rheumatology, EarlyView.
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher, Iain B. McInnes, Enrique R. Soriano, Joseph F. Merola, Paul Bird, Vinod Chandran, Edaire Cheng, Elena Reynoso, Warner Chen, Maoji Li, Lianne S. Gensler, Philip J. Mease, Christopher T. Ritchlin   +12 more
wiley   +1 more source